EUVIMEDEUVIMED entdecken
Open Access

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

Carmen Tur, Pere Carbonell-Mirabent, Álvaro Cobo-Calvo, Susana Otero-Romero, Georgina Arrambide, Luciana Midaglia, Joaquín Castilló, Ángela Vidal-Jordana, Breogán Rodríguez-Acevedo, Ana Zabalza, Ingrid Galán, Carlos Nos und 9 weitere

JAMA Neurology · 01.02.2023 · 80 (2) · 151

DOI: 10.1001/jamaneurol.2022.4655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Neurology, erschienen am 01.02.2023. Verfasst von Carmen Tur und 20 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Centre of Catalonia, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelo…. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 263-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Progression independent of relapse activity (PIRA) is the main event responsible for irreversible disability accumulation in relapsing multiple sclerosis (MS).

Objective

To investigate clinical and neuroimaging predictors of PIRA at the time of the first demyelinating attack and factors associated with long-term clinical outcomes of people who present with PIRA. Design, Setting, and Participants This cohort study, conducted from January 1, 1994, to July 31, 2021, included patients with a first demyelinating attack from multiple sclerosis; patients were recruited from 1 study center in Spain. Patients were excluded if they refused to participate, had alternative diagnoses, did not meet protocol requirements, had inconsistent demographic information, or had less than 3 clinical assessments. Exposures Exposures included (1) clinical and neuroimaging features at the first demyelinating attack and (2) presenting PIRA, ie, confirmed disability accumulation (CDA) in a free-relapse period at any time after symptom onset, within (vs after) the first 5 years of the disease (ie, early/late PIRA), and in the presence (vs absence) of new T2 lesions in the previous 2 years (ie, active/nonactive PIRA). Main Outcomes and Measures Expanded Disability Status Scale (EDSS) yearly increase rates since the first attack and adjusted hazard ratios (HRs) for predictors of time to PIRA and time to EDSS 6.0.

Results

Of the 1128 patients (mean [SD] age, 32.1 [8.3] years; 781 female individuals [69.2%]) included in the study, 277 (25%) developed 1 or more PIRA events at a median (IQR) follow-up time of 7.2 (4.6-12.4) years (for first PIRA). Of all patients with PIRA, 86 of 277 (31%) developed early PIRA, and 73 of 144 (51%) developed active PIRA. Patients with PIRA were slightly older, had more brain lesions, and were more likely to have oligoclonal bands than those without PIRA. Older age at the first attack was the only predictor of PIRA (HR, 1.43; 95% CI, 1.23-1.65; P < .001 for each older decade). Patients with PIRA had steeper EDSS yearly increase rates (0.18; 95% CI, 0.16-0.20 vs 0.04; 95% CI, 0.02-0.05; P < .001) and an 8-fold greater risk of reaching EDSS 6.0 (HR, 7.93; 95% CI, 2.25-27.96; P = .001) than those without PIRA. Early PIRA had steeper EDSS yearly increase rates than late PIRA (0.31; 95% CI, 0.26-0.35 vs 0.13; 95% CI, 0.10-0.16; P < .001) and a 26-fold greater risk of reaching EDSS 6.0 from the first attack (HR, 26.21; 95% CI, 2.26-303.95; P = .009). Conclusions and Relevance Results of this cohort study suggest that for patients with multiple sclerosis, presenting with PIRA after a first demyelinating event was not uncommon and suggests an unfavorable long-term prognosis, especially if it occurs early in the disease course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansFemaleAdultCohort StudiesChronic DiseasePrognosisRecurrence

Autor:innen und Institutionen

  • Multiple Sclerosis Centre of Catalonia, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain.

Zitieren

APA

Tur, C., Carbonell-Mirabent, P., Cobo-Calvo, Á., Otero-Romero, S., Arrambide, G., Midaglia, L., Castilló, J., Vidal-Jordana, Á., Rodríguez-Acevedo, B., Zabalza, A., Galán, I., Nos, C., Salerno, A., Auger, C., Pareto, D., Comabella, M., Río, J., Sastre-Garriga, J., Rovira, À., …, & Montalban, X. (2023). Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis. JAMA Neurology, 80(2), 151. https://doi.org/10.1001/jamaneurol.2022.4655

Vancouver

Tur C, Carbonell-Mirabent P, Cobo-Calvo Á, Otero-Romero S, Arrambide G, Midaglia L, et al. Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis. JAMA Neurology. 2023;80(2):151. doi:10.1001/jamaneurol.2022.4655

BibTeX
@article{Tur2023,
  author = {Tur, Carmen and Carbonell-Mirabent, Pere and Cobo-Calvo, Álvaro and Otero-Romero, Susana and Arrambide, Georgina and Midaglia, Luciana and Castilló, Joaquín and Vidal-Jordana, Ángela and Rodríguez-Acevedo, Breogán and Zabalza, Ana and Galán, Ingrid and Nos, Carlos and Salerno, Annalaura and Auger, Cristina and Pareto, Deborah and Comabella, Manuel and Río, Jordi and Sastre-Garriga, Jaume and Rovira, Àlex and Tintoré, Mar and Montalban, Xavier},
  title = {Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis},
  journal = {JAMA Neurology},
  year = {2023},
  volume = {80},
  number = {2},
  pages = {151},
  doi = {10.1001/jamaneurol.2022.4655}
}
Kostenlos starten →